RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested
Plus, an apparent magnification of effect in SYMPLICITY HTN-3
Source: medpagetoday.com
Stay updated with breaking news from Symplicity Flex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus, an apparent magnification of effect in SYMPLICITY HTN-3
BOSTON — Radiofrequency renal denervation for uncontrolled hypertension appeared to demonstrate durable BP reduction out to 3 years in the setting of maximal antihypertensive therapy, a speaker reported.The results of the long-term and final follow-up of the SYMPLICITY HTN-3 trial of radiofrequency renal denervation for resistant hypertension using a first-generation catheter (Symplicity
A taste of clinical outcomes data when a randomized trial is unlikely